Literature DB >> 7224349

Respiratory disease in Utah coal miners.

W N Rom, R E Kanner, A D Renzetti, J W Shigeoka, H W Barkman, M Nichols, W A Turner, M Coleman, W E Wright.   

Abstract

Two hundred forty-two Utah underground coal miners volunteered to participate in a respiratory disease study. They were an older group (mean, 56 years of age) and had spent a mean of 29 years in the coal-mining industry. The prevalence of chronic bronchitis was 57%, and that of coal worker's pneumoconiosis, 25%; only one worker had progressive massive fibrosis. Significant impairment of pulmonary function was found among those with a history of cigarette smoking. Chronic bronchitis or coal worker's penumoconiosis among nonsmokers did not impair pulmonary function. There was a significant association among the nonsmokers between increasing exposure to coal dust and coal worker's pneumoconiosis, but not for changes in pulmonary function. Coal mine dust had a significant influence in causing the symptom complex of chronic cough and sputum production, and coal worker's pneumoconiosis.

Entities:  

Mesh:

Year:  1981        PMID: 7224349     DOI: 10.1164/arrd.1981.123.4.372

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  4 in total

1.  Prevalence of chronic bronchitis among US Hispanics from the Hispanic Health and Nutrition Examination Survey, 1982-84.

Authors:  K M Bang; P J Gergen; M Carroll
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

2.  Compensation for occupational disease with multiple causes: the case of coal miners' respiratory diseases.

Authors:  J L Weeks; G R Wagner
Journal:  Am J Public Health       Date:  1986-01       Impact factor: 9.308

3.  Respiratory impairment and symptoms as predictors of early retirement with disability in US underground coal miners.

Authors:  R G Ames; R B Trent
Journal:  Am J Public Health       Date:  1984-08       Impact factor: 9.308

4.  Chronic cough due to occupational factors.

Authors:  David A Groneberg; Dennis Nowak; Anke Wussow; Axel Fischer
Journal:  J Occup Med Toxicol       Date:  2006-02-02       Impact factor: 2.646

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.